Skip to main content
Download PDF

A randomized controlled trial of WeChat-based cognitive behavioral therapy intervention to improve cancer-related symptoms in gynecological cancer survivors: study protocol

BMC Health Services Research volume 22, Article number: 1052 (2022) Cite this article

Abstract

Background

Gynecological malignant patients often have significant psychological and physical problems. The feasibility and generalizability of traditional intervention method is low due to the high time and labor cost, large number of gynecological malignant tumor patients in China, as well as shortage of health professionals. Therefore, it is necessary to design an alternative, innovative, and easily accessible intervention method. This study aims to evaluate the effect of WeChat-based intervention on anxiety, depression and disease-related symptoms of patients with gynecological malignant tumors during rehabilitation.

Methods

A single-blinded, randomized, controlled, parallel-group pre-test and repeated post-test design will be conducted. A total of 76 participants will be randomly divided into the intervention group and control group. Anxiety and depression, disease-related symptoms, coping ability, benefit finding and quality of life will be measured at baseline and repeated immediately after the intervention (test 1), 3 months (test 2) and 6 months (test 3) after the intervention.

Discussion

As the first randomized controlled trial with rigorous research design for patients with gynecological malignant tumors in the rehabilitation stage in China, this study will provide evidences for the effectiveness of the WeChat platform during intervention of patients with gynecological malignant tumors in the rehabilitation stage. The results are helpful to further explore the effect of WeChat-based intervention on improving patients' anxiety and depression, disease-related symptoms, and quality of life.

Trial registration

Chinese Clinical Trial Registry: ChiCTR2100053450, Registered 21 November 2021,http://www.chictr.org.cn/searchproj.aspx

Peer Review reports

Background

Gynecological malignant tumor is a major disease threatening women's health, and has high incidence and high mortality [1]. There are many types of gynecological malignant tumors, among which ovarian cancer, cervical cancer, and endometrial cancer are the most common [2]. In recent years, the incidence rate has been increasing steadily, and the age of onset has gradually become younger. According to the report released by the International Agency for Research on Cancer (IARC), there were about 1,246,000 new cases of ovarian cancer, cervical cancer, and endometrial cancer and about 584,000 deaths in 2018 alone [1, 2]. The new cases of these three tumors in Chinese women is about 233,000, accounting for one fifth of the global cases, which greatly threatens the health and life of these patients [2, 3].

To treat gynecological malignant tumors, comprehensive treatment is generally needed, such as surgery, chemotherapy, or radiotherapy, which often leads to anatomical changes of the patient's reproductive system, menopause, vaginal dryness, hot flashes, and sexual intercourse pain [3]. The adverse effects result in damage to the reproductive, sexual, and urinary functions. Patients often have significant sexual psychological problems and body image disorders [4]. Moreover, the incidence of anxiety and depression was found to be high among these patients [5, 6]. Currently, the outcome for the treatment of malignant tumors is evaluated by not only the remission of clinical symptoms and the prolongation of survival time, but also the quality of life. Therefore, more attention should be paid to the psychological problems of patients with gynecological malignant tumors in the rehabilitation stage, in the purpose of alleviating symptoms and improving the patients’ quality of life.

A number of existing studies have shown that psychological intervention played a positive role in improving the sexual psychological problems and emotional disorders in patients with gynecological malignant tumors. Proper intervention satisfied the emotional and psychological needs of patients and improved the physical function by alleviating such symptoms as anxiety, depression, fatigue, pain, and insomnia [7,8,9]. Studies based in China have also confirmed the positive effect of psychological intervention for patients with gynecological malignant tumors [10, 11]. Recently, the cognitive behavior therapy (CBT), as a psychotherapy method in survival nursing, has attracted more and more attention. CBT plays an important role in group psychotherapy. By changing patients' incorrect cognition of the disease and conducting behavioral training, CBT helps the patients to establish reasonable cognition, change poor psychological state and negative coping style, thereby improving disease-related symptoms and the quality of life [12,13,14,15]. Many studies have shown that CBT is a beneficial treatment option for a variety of cancer patients [16,17,18]. Hersch et al. showed that CBT reduced psychological pain, anxiety, and depression [19]. However, current studies on CBT intervention for cancer patients are mainly focused on breast cancer, followed by prostate cancer [20]. Few studies have been carried out on patients with gynecological malignant tumors.

Moreover, traditional CBT interventions are carried out in a face-to-face setting. Studies have pointed out that due to cultural factors, most patients in China were unwilling to discuss sex psychology problems publicly [21, 22]. Stead et al. showed that only about a quarter of medical staff have been talked to about this problem. Thus, in many cases, the special psychological problems of patients with gynecological malignant tumors were not addressed [23]. Instead of face-to-face intervention, gynecological malignant tumor patients are more willing to participate in online support groups, due to the anonymity of discussion, which helped the patients feel comfortable talking about and solve these problems [24]. Further, the feasibility and generalizability of traditional intervention method is low due to the high time and labor cost, large number of gynecological malignant tumor patients in China, as well as shortage of health professionals. Therefore, it is necessary to design an alternative, innovative, and easily accessible intervention method. The development of internet has enable the possibility of convenient and accessible of online, virtual intervention, the Internet-based intervention can be conducted through multiple media formats to customize information, which saves participants' time and cost, and makes it easier to participate. Thus, internet-based intervention is an innovative and convenient intervention method, and has the ability to reach more target patients [25, 26]. Internet cognitive behavioral therapy (ICBT) produced the same results as face-to-face therapy in terms of mental health improvement. ICBT is being increasingly adopted in the study of physical health of patients with chronic diseases [27, 28]. A review by Andersson et al. showed that the effects of ICBT and face-to-face CBT on a series of mental and physical diseases were the same, which provided evidences for the adoption of ICBT [29].

In China, WeChat is the most widely used social network platform. At present, there are 902 million active users every day, and each user spend an average of 66 min on the platform every day [30]. WeChat has many different functions, such as private or group texts or voice messages, video calls or meetings, electronic document transmission, subscription and browsing of public accounts and information publishing [31, 32]. Because WeChat has a variety of interactive functions and a large amount of users, and is convenient, timely, and affordable [32], it has been slowly changing the way people receive information. It breaks the time and space limitations of traditional classrooms, improves autonomous learning, and strengthens cooperation with peers [33]. WeChat has been used for behavioral intervention and disease prevention and control, such as cancer, malaria, asthma, chronic sinusitis, diabetes and weight loss [34,35,36,37,38,39]. Some studies have used WeChat-based group intervention for malignant tumor patients. The attrition rate of participants was relatively low and the acceptability among users was good. Some patients said that they have found a sense of belonging in the patient group, and have "people and places that can speak their hearts". As a result, both online and offline communication was very active [40]. WeChat can optimize the communication between patients and medical staff [32],and when doctors withdrew from the WeChat group after the group intervention, group members can still maintain interactive communication in the WeChat group. Through the platform, the members spontaneously organized offline collective outings and other activities to provide continuous psychological support between group members [40]. However, there is still no study on the effect of WeChat on patients with gynecological malignant tumors in the rehabilitation stage. Therefore, the objective of the present study is to explore the WeChat-based CBT(WCBT) intervention model. By carrying out psychological intervention and follow-up management of patients with gynecological malignant tumors through WeChat, its impact on the patients’ physical and psychological symptoms will be explored.

Methods/design

Aims

The objective of this study was to evaluate the effect of CBT based on the WeChat platform on anxiety, depression, and disease-related symptoms of patients with gynecological malignant tumors in the rehabilitation stage, thereby establishing an intervention model to improve the patient’s coping ability, benefit finding and quality of life. The study hypothesizes that compared with the control group at baseline, test 1, test 2 and test 3, patients in the intervention group will report statistically significant:

  1. 1.

    The degree of anxiety and depression is decreased;

  2. 2.

    Disease-related symptoms are reduced;

  3. 3.

    Coping ability, benefit finding and quality of life are improved.

Study design

Trial design

A single-blinded, randomized, controlled, parallel group pre-test, and repeated post-test design will be conducted to investigate the effect of WeChat-based Cognitive behavioral therapy for Chinese gynecological cancer survivors.

SPIRIT statement

The study follows the SPIRIT 2013 Statement and the guidelines for the Standard Protocol of Clinical Trials [41]. Figure 1 is available for this protocol. The Consolidated Standards of Reporting Trials (CONSORT) [42] flowchart is presented in Fig. 2.

Fig. 1
figure 1

SPIRIT schedule of enrolment, interventions, and assessments

Full size image
Fig. 2
figure 2

CONSORT flowchart of the study. Note: HADS: Hospital Anxiety and Depression Scale; FACT-G: Functional Assessment of Cancer Therapy—General; MSAS-SF: The Chinese version of the Memorial Symptom Assessment Scale- Short Form; Mini-MAC: Mini-Mental Adjustment to Cancer Scale; BFS: Benefit-Finding of Cancer Patients Scale

Full size image

Study setting and participants

The study will be conducted in a tertiary public hospital affiliated to a university in China. Patients with gynecological malignant tumors (i.e., cervical cancer, endometrial cancer, and ovarian cancer) will be recruited in the outpatient department of the hospital.

Inclusion criteria

(1) patients with pathologically confirmed cervical cancer, endometrial cancer, and ovarian cancer; (2) patients who have completed surgery and / or radiotherapy and chemotherapy and have entered the rehabilitation stage; (3) Age 18–65 years; and (4) Kamofsky performance status (KPS) score > 60 points [43].

Exclusion criteria

(1) patients with history of mental illness, material dependence or consciousness disorder; (2) patients with hearing and visual impairment; and (3) patients undergoing any form of psychotherapy.

Drop-out criteria

(1) the disease progressed to a great extent during the intervention (tumor recurrence or metastasis); and (2) Other forms of psychotherapy are received during the study.

Sample size will be estimated based on previous research with a medium to small effect size [44]. With a power of 0.90, an alpha set at 0.05, and an effect size of 0.47 for the primary outcome of FACT-G scores, each group will be 29 women [21]. We estimate a 30% attrition rate based on an attrition rate of 28.8% in previous research [45]. A minimum of 76 women (38 in each group) are required.

Recruitment

The participants will be recruited from the gynecology outpatient department. Posters and flyers about this study will be posted and distributed in the outpatient center. An information sheet about the study will be given to the patients who verbally expressed their intention of participation. In order to make sure that they have enough time to read the information sheet, discuss with family members, and make the final decision, one week will be given to the patients. If a patient agrees, the contents, procedures, and rules of the study will be explained to her, and she will be asked to sign an informed consent. At the same time, oncology experts of this study will review the participants' medical records to obtain information about disease diagnosis, pathology, past and current cancer treatment, and patients' treatment compliance. Subjects will be screened according to the inclusion criteria. The recruitment period is expected to last for 3 months. Data will be collected before randomization (baseline), immediately after intervention (test 1), 3 months after intervention (test 2) and 6 months after intervention (test 3). The trial will be conducted in accordance with the Declaration of Helsinki and will take place from Jun 1, 2022 to Dec 31, 2023.

Randomization and blinding

Using the Excel software, the participants will be randomly divided into an intervention group and a control group with a ratio of 1:1. The randomization result will be placed in an opaque sealed envelope. Throughout the study, the participants, evaluators who will collect the data, and the data analysts will be blinded from the grouping information.

Intervention

Patients in the control group will receive routine outpatient follow-up, during the visits, they will be provided general health recommendation, brief medication and exercise guidance, and information related to mental health. In addition, telephone follow-up will be carried out once a month. The patients are allowed to ask questions related to the disease through WeChat or mobile phone, yet they cannot participate in the online educational intervention.

For the intervention group, patients will receive group CBT for 10 weeks, carried out by psychiatrists, psychological counselors, and oncology nurses who had received CBT training. The details of intervention are described in Table 1. For the purpose of better communication, 38 patients in the intervention group were divided into three WeChat groups (12–13 patients in each group). The same intervention scheme was used in the three groups. Group CBT professionals will be invited to evaluate and supervise the intervention process.

Table 1 The details of intervention
Full size table

The contents of CBT intervention is based on currently mature cognitive and behavioral treatment programs in the world [46,47,48], which includes psychological education and self-monitoring, cognitive reconstruction, behavior correction, relaxation training, and problem-solving technique. The contents can be divided into three components: (1) cognitive reconstruction: the purpose is to explain disease- and psychology-related knowledge for patients at different stages, such as the risk factors, common treatment methods, prognosis, common side effects and treatments, and common psychological problems of gynecological malignant tumors; (2) cognitive behavioral therapy, the purpose of which is to identify and change incorrect psychological cognition, and train the patient’s coping skills. It will be used through the treatment plan of this study. The core is to help patients correctly manage stress and improve self-confidence, identify and optimize the use of social support resources, etc.; (3) support expression. A topic will be selected for WeChat group discussion. Members share their experiences and emotional exchanges about the topic, and the members will be encouraged to talk about stress and negative emotions, so as to help members support each other and reduce loneliness. There will be 6 topics throughout the study: (a) start treatment with your medical team. Including self-introduction and mutual understanding; joint formulation of group norms; sharing of the illness experience and current troubles; expressing the feelings and hopes of participating in the group; (b) management of symptoms and side effects, such as fatigue, pain, and insomnia. In addition, how to identify physical tension and use relaxation techniques (meditation, muscle relaxation, etc.); (c) the role of emotion during rehabilitation. How to identify negative thoughts and share them; (d) body image and sex; (e) family and friends; and(f) self-management of a healthy lifestyle.

First, online education information, in the format of texts, pictures, sound and video will be shared twice a week through WeChat. Before or after the release of information, the patients will be reminded via WeChat notifications. The learning time per week should be no less than 1 h. All previous information will be available for the participants at any time throughout the study. Secondly, the participants are required to carefully study the educational content, and turn in homework to a researcher. Homework includes learning experience, self-reflection diary, self-portrait videos of various relaxation exercises, etc., the purpose of homework is to improve the self-learning and monitoring ability of the participants, and then the participants are expected to extend the methods to their daily life, thereby strengthening the effect of intervention. In addition, discussions in the WeChat group will be held every 1–2 weeks based on the educational content released weekly. A gift will be given to the participants who actively participate in the discussion. Throughout the intervention, the participants will be encouraged to raise questions and share their experiences at any time.

Outcome measurements

Primary outcomes

Hospital Anxiety and Depression Scale (HADS) [46]. There are 14 items, including 7 items on anxiety and 7 items on depression. A score of 0–7 means the participant is asymptomatic, 8–10 is suspicious, and 11–21 means symptomatic. Cronbach α coefficients of the total scale, as well as the anxiety and depression subscales are 0.88, 0.81 and 0.81, respectively [49].

Memorial Symptom Assessment Scale–Short Form (MSAS-SF), which is used to evaluate the characteristics of physical and psychological symptoms of cancer patients [50]. There are 32 items consisting of 2 subscales: physical symptoms and psychological symptoms. The incidence and frequency of each symptom will be evaluated. The Cronbach's alpha coefficient ranged from 0.84 to 0.91 [51].

Secondary outcomes

Functional Assessment of Cancer Therapy–General (FACT-G). It is a general scale used to evaluate the cancer patients' quality of life. There are 27-item consisting of 4 subscales: physical, social, emotional and functional wellbeing (total score of 0–108; higher scores = better QoL), Cronbach α is 0. 88, 0. 82, 0. 87, 0. 83,respectively [52].

Coping, which is measured with the mini-Mental Adjustment to Cancer Scale (mini-MAC) [53], a 29-item scale yielding 5 factors: Fighting Spirit, Helplessness/Hopelessness, Anxious Preoccupation, Fatalism, and Cognitive Avoidance. Items are responded to on a 4-point scale ranging from ‘definitely does not apply’ to ‘definitely does apply’.

Benefit Finding of Cancer Patients Scale(BFS). The scale was adapted by Weaver et al. [54], which was employed in prior studies of gynecological cancer patients [55]. Benefits included both interpersonal and intrapersonal changes from cancer. Higher scores indicated perceiving more benefits from cancer.

Other outcomes

Demographics and clinical variables. The information will be collected for each patient, including age, sex, marital status, educational level, occupation, work status, level of income, diagnosis, stage of disease, and treatment type.

WeChat usage data, which is used to evaluate the usage of WeChat official account by the participant, such as the frequency of login, browsing time.

Data collection

The patients will be identifed by a unique study inclusion number and by the frst initial of their surname and of their given name. Baseline data will be collected face-to-face immediately after the patients signing the informed consent. Test 1 will be performed immediately after the intervention, test 2 and test 3 will be performed 3 months and 6 months after the intervention, respectively. The "questionnaire star" app on the WeChat platform will be used during test 1, test 2 and test 3 to send online electronic questionnaire to each participant. The questionnaires included HADS, FACT-G, MSAS-SF, mini-MAC, BFS, socio-demographics, and clinical data.

Statistical analysis

All data were analyzed using the Statistical Package for Social Sciences 22.0(SPSS Inc., Chicago, IL, USA). Two researchers will carry out data analyses.Participants’ characteristics and outcome scores were summarized using means ± standard deviation (SD) or medians [interquartile ranges (IQR)] for continuous variables or frequencies (percentages) for categorical variables. Baseline characteristics and outcomes were compared using independent samples t-test or Mann–Whitney U test from continuous variables and chi-squared test for categorical variables between the intervention and control group. p values < 0.05 were considered statistically significant. All analyses will be conducted on an intention-to-treat basis.

Validity and reliability

The feasibility of this study design is high, and the measurement tools have high effectiveness and reliability. The statistical analysis method is appropriate, which can effectively reduce error. In addition, because the evaluators and data analysts are blinded from the patient group, biases in the evaluation of intervention outcome can be effectively controlled.

Discussion

Due to the lack of human and material resources in China, cancer patients are often not provided with effective interventions to ensure their physical and mental health. Under China's current medical and health system, it is more and more imperative to develop a time-saving, efficient, and accessible psychological intervention model that is suitable for local communities. The present study will be the first RCT on the use of CBT through WeChat on Chinese patients with gynecological malignant tumors in the rehabilitation stage. This study can provide evidences for the effectiveness of WeChat on supporting the rehabilitation of patients with gynecological malignant tumors.

Limitations

In this study, a randomized controlled trial is design to study the effect of intervention. There are some limitations: (1) the sample size of the study is small, and due to limited resources, all participants are from level-3 hospitals, which may compromise the applicability of the study results. (2) Only patients with gynecological malignant tumors are included in this study, and the results of such intervention in other cancer populations needs to be verified. (3) the participants are limited to those who are willing to participate in this study through the WeChat platform, and the results cannot be extended to those who refuse to or cannot use WeChat.

Availability of data and materials

Not applicable.

Abbreviations

IARC:

International Agency for Research on Cancer

ICBT:

Internet cognitive behavioral therapy

WCBT:

WeChat-Based Cognitive Behavioral Therapy

HADS:

Hospital Anxiety and Depression Scale

FACT-G:

Functional Assessment of Cancer Therapy—General

MSAS-SF:

The Chinese version of the Memorial Symptom Assessment Scale- Short Form

Mini-MAC:

Mini-Mental Adjustment to Cancer Scale

BFS:

Benefit-Finding of Cancer Patients Scale

References

  1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492.

    Article  PubMed  Google Scholar 

  2. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32. https://doi.org/10.3322/caac.21338.

    Article  PubMed  Google Scholar 

  3. Carter J, Penson R, Barakat R, Wenzel L. Contemporary quality of life issues affecting gynecologic cancer survivors. Hematol Oncol Clin North Am. 2012;26(1):169–94. https://doi.org/10.1016/j.hoc.2011.11.001.

    Article  PubMed  Google Scholar 

  4. Classen CC, Chivers ML, Urowitz S, Barbera L, Wiljer D, O’Rinn S, Ferguson SE. Psychosexual distress in women with gynecologic cancer: a feasibility study of an online support group. Psychooncology. 2013;22(4):930–5. https://doi.org/10.1002/pon.3058.

    Article  PubMed  Google Scholar 

  5. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psychooncology. 2001;10(1):19–28. https://doi.org/10.1002/1099-1611(200101/02)10:13.0.CO;2-6.

    Article  CAS  PubMed  Google Scholar 

  6. Abbott-Anderson K, Kwekkeboom KL. A systematic review of sexual concerns reported by gynecological cancer survivors. Gynecol Oncol. 2012;124(3):477–89. https://doi.org/10.1016/j.ygyno.2011.11.030.

    Article  PubMed  Google Scholar 

  7. Manne SL, Kashy DA, Rubin S, Hernandez E, Bergman C. Therapist and patient perceptions of alliance and progress in psychological therapy for women diagnosed with gynecological cancers. J Consult Clin Psychol. 2012;80(5):800–10. https://doi.org/10.1037/a0029158.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Caldwell R, Classen C, Lagana L, McGarvey E, Baum L, Duenke SD, et al. Changes in sexual functioning and mood among women treated for gynecological cancer who receive group therapy: a pilot study. J Clin Psychol Med Settings. 2003;10(3):149–56. https://doi.org/10.1023/A:1025402610404.

    Article  Google Scholar 

  9. Chow KM, Chan CW, Chan JC, Choi KK, Siu KY. A feasibility study of a psychoeducational intervention program for gynecological cancer patients. Eur J Oncol Nurs. 2014;18(4):385–92. https://doi.org/10.1016/j.ejon.2014.03.011.

    Article  PubMed  Google Scholar 

  10. Liu P. Effects of psychological intervention on post-operation patients with gynecological neoplasms (in Chinese). Chin J Med. 2016;51(11):76–8. https://doi.org/10.3969/j.issn.1008-1070.2016.11.022.

    Article  CAS  Google Scholar 

  11. Zhuang N, Wang J. Influence of Nursing Care on the Anxiety-depression of Women with Different Gynecological Diseases (in Chinese). J Nurs Sci. 2007;16:24–5. https://doi.org/10.3969/j.issn.1001-4152.2007.16.011.

    Article  Google Scholar 

  12. Benjamin CL, Puleo CM, Settipani CA, Brodman DM, Edmunds JM, Cummings CM, Kendall PC. History of cognitive-behavioral therapy in youth. Child Adolesc Psychiatr Clin N Am. 2011;20(2):179–89. https://doi.org/10.1016/j.chc.2011.01.011.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Kaczkurkin AN, Foa EB. Cognitive-behavioral therapy for anxiety disorders: an update on the empirical evidence. Dialogues Clin Neurosci. 2015;17(3):337–46. https://doi.org/10.31887/DCNS.2015.17.3/akaczkurkin.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Ye M, Du K, Zhou J, Zhou Q, Shou M, Hu B, Jiang P, Dong N, He L, Liang S, Yu C, Zhang J, Ding Z, Liu Z. A meta-analysis of the efficacy of cognitive behavior therapy on quality of life and psychological health of breast cancer survivors and patients. Psychooncology. 2018;27(7):1695–703. https://doi.org/10.1002/pon.4687.

    Article  PubMed  Google Scholar 

  15. Zhang Q, Gao X, Liu S, Yu L, Zhu J, Qiu S. Therapies for cognitive impairment in breast cancer survivors treated with chemotherapy: A protocol for systematic review. Medicine (Baltimore). 2020;99(19):e20092. https://doi.org/10.1097/MD.0000000000020092.

    Article  Google Scholar 

  16. Brothers BM, Yang HC, Strunk DR, Andersen BL. Cancer patients with major depressive disorder: testing a biobehavioral/cognitive behavior intervention. J Consult Clin Psychol. 2011;79(2):253–60. https://doi.org/10.1037/a0022566.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Greer S. CBT for emotional distress of people with cancer: some personal observations. Psychooncology. 2008;17(2):170–3. https://doi.org/10.1002/pon.1205.

    Article  PubMed  Google Scholar 

  18. Lee H, Lim Y, Yoo MS, Kim Y. Effects of a nurse-led cognitive-behavior therapy on fatigue and quality of life of patients with breast cancer undergoing radiotherapy: an exploratory study. Cancer Nurs. 2011;34(6):E22-30. https://doi.org/10.1097/NCC.0b013e31820d1734.

    Article  PubMed  Google Scholar 

  19. Park JS, Oh YJ. Development and Evaluation of the Psychosocial Distress Nursing Intervention for Patients with Gynecological Cancer. Korean J Adult Nurs. 2012;24(3):219–31. https://doi.org/10.7475/kjan.2012.24.3.219.

    Article  Google Scholar 

  20. Addison S, Shirima D, Aboagye-Mensah EB, Dunovan SG, Pascal EY, Lustberg MB, Arthur EK, Nolan TS. Effects of tandem cognitive behavioral therapy and healthy lifestyle interventions on health-related outcomes in cancer survivors: a systematic review. J Cancer Surviv. 2021;6:1–24. https://doi.org/10.1007/s11764-021-01094-8.

    Article  Google Scholar 

  21. Li ZM, Pang Y, Li JJ, Tang LL. A randomized controlled trial of group psychotherapy on emotions and quality of life in patients with gynecological cancer in convalescence stage (in Chinese). Chin Ment Health J. 2020;34(12):977–82. https://doi.org/10.3969/j.issn.1000-6729.2020.12.002.

    Article  Google Scholar 

  22. Sun L, Liu K, Li X, Zhang Y, Huang Z. Benefit-finding experiences of cervical cancer survivors in rural Yunnan province, China: A qualitative study. Nurs Open 2021:13. https://doi.org/10.1002/nop2.962.

  23. Stead ML, Brown JM, Fallowfield L, Selby P. Lack of communication between healthcare professionals and women with ovarian cancer about sexual issues. Br J Cancer. 2003;88(5):666–71. https://doi.org/10.1038/sj.bjc.6600799.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Wiljer D, Urowitz S, Barbera L, Chivers ML, Quartey NK, Ferguson SE, To M, Classen CC. A qualitative study of an internet-based support group for women with sexual distress due to gynecologic cancer. J Cancer Educ. 2011;26(3):451–8. https://doi.org/10.1007/s13187-011-0215-1.

    Article  PubMed  Google Scholar 

  25. van den Berg SW, Gielissen MF, Ottevanger PB, Prins JB. Rationale of the BREAst cancer e-healTH [BREATH] multicentre randomised controlled trial: an internet-based self-management intervention to foster adjustment after curative breast cancer by decreasing distress and increasing empowerment. BMC Cancer. 2012;7(12):394. https://doi.org/10.1186/1471-2407-12-394.

    Article  Google Scholar 

  26. Post KE, Flanagan J. Web based survivorship interventions for women with breast cancer: An integrative review. Eur J Oncol Nurs. 2016;25:90–9. https://doi.org/10.1016/j.ejon.2016.10.004.

    Article  PubMed  Google Scholar 

  27. Beatty L, Lambert S. A systematic review of internet-based self-help therapeutic interventions to improve distress and disease-control among adults with chronic health conditions. Clin Psychol Rev. 2013;33(4):609–22. https://doi.org/10.1016/j.cpr.2013.03.004.

    Article  PubMed  Google Scholar 

  28. Cuijpers P, van Straten A, Andersson G. Internet-administered cognitive behavior therapy for health problems: a systematic review. J Behav Med. 2008;31(2):169–77. https://doi.org/10.1007/s10865-007-9144-1.

    Article  PubMed  Google Scholar 

  29. Andersson G, Cuijpers P, Carlbring P, Riper H, Hedman E. Guided Internet-based vs face-to-face cognitive behavior therapy for psychiatric and somatic disorders: a systematic review and meta-analysis. World Psychiatry. 2014;13(3):288–95. https://doi.org/10.1002/wps.20151.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Techjury. 21+ Exciting We Chat Statistics. 2021. Available online: https://techjury.net/blog/wechat-statistics/#gref (Accessed on 28 Oct 2021).

  31. Wang Z, Wang S, Zhang Y, Jiang X. Social media usage and online professionalism among registered nurses: A cross-sectional survey. Int J Nurs Stud. 2019;98:19–26. https://doi.org/10.1016/j.ijnurstu.2019.06.001.

    Article  PubMed  Google Scholar 

  32. Zhang X, Wen D, Liang J, Lei J. How the public uses social media wechat to obtain health information in china: a survey study. BMC Med Inform Decis Mak. 2017;17(S2):66. https://doi.org/10.1186/s12911-017-0470-0.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Zeng F, Deng G, Wang Z, Liu L. WeChat: a new clinical teaching tool for problem-based learning. Int J Med Educ. 2016;25(7):119–21. https://doi.org/10.5116/ijme.5708.e5c4.

    Article  Google Scholar 

  34. Zhang X, Xiao H, Chen Y. Evaluation of a WeChat-based life review programme for cancer patients: A quasi-experimental study. J Adv Nurs. 2019;75(7):1563–74. https://doi.org/10.1111/jan.14018.

    Article  PubMed  Google Scholar 

  35. Li W, Han LQ, Guo YJ, Sun J. Using WeChat official accounts to improve malaria health literacy among Chinese expatriates in Niger: an intervention study. Malar J. 2016;15(1):567. https://doi.org/10.1186/s12936-016-1621-y.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Cao Y, Lin SH, Zhu D, Xu F, Chen ZH, Shen HH, Li W. WeChat Public Account Use Improves Clinical Control of Cough-Variant Asthma: A Randomized Controlled Trial. Med Sci Monit. 2018;24:1524–32. https://doi.org/10.12659/msm.907284.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Feng S, Liang Z, Zhang R, Liao W, Chen Y, Fan Y, Li H. Effects of mobile phone WeChat services improve adherence to corticosteroid nasal spray treatment for chronic rhinosinusitis after functional endoscopic sinus surgery: a 3-month follow-up study. Eur Arch Otorhinolaryngol. 2017;274(3):1477–85. https://doi.org/10.1007/s00405-016-4371-0.

    Article  PubMed  Google Scholar 

  38. Dong Y, Wang P, Dai Z, Liu K, Jin Y, Li A, Wang S, Zheng J. Increased self-care activities and glycemic control rate in relation to health education via Wechat among diabetes patients: A randomized clinical trial. Medicine (Baltimore). 2018;97(50):e13632. https://doi.org/10.1097/MD.0000000000013632.

    Article  Google Scholar 

  39. He C, Wu S, Zhao Y, Li Z, Zhang Y, Le J, Wang L, Wan S, Li C, Li Y, Sun X. Social Media-Promoted Weight Loss Among an Occupational Population: Cohort Study Using a WeChat Mobile Phone App-Based Campaign. J Med Internet Res. 2017;19(10):e357. https://doi.org/10.2196/jmir.7861.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Hu ZF, Wan CX, Xu L, Huang Y. The effectiveness of wechat-based trasitional care in patients with ankylosing spondylitis (in Chinese). Chin J Nurs. 2015;50(2):175–8. https://doi.org/10.3761/j.issn.0254-1769.2015.02.011.

    Article  Google Scholar 

  41. Chan AW, Tetzlaff JM, Gøtzsche PC, Altman DG, Mann H, Berlin JA, Dickersin K, Hróbjartsson A, Schulz KF, Parulekar WR, Krleza-Jeric K, Laupacis A, Moher D. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;8(346):e7586. https://doi.org/10.1136/bmj.e7586.

    Article  Google Scholar 

  42. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. J Pharmacol Pharmacother. 2010;1(2):100–7. https://doi.org/10.4103/0976-500X.72352.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky Performance Status Scale An examination of its reliability and validity in a research setting. Cancer. 1984;53(9):2002–7. https://doi.org/10.1002/1097-0142(19840501)53:9%3c2002::aid-cncr2820530933%3e3.0.co;2-w.

    Article  CAS  PubMed  Google Scholar 

  44. Cohen J. Statistical power analysis. Curr Dir Psychol Sci. 2005;1(3):98–101. https://doi.org/10.1007/0-387-26528-7_4.

    Article  Google Scholar 

  45. Savard J, Ivers H, Savard MH, Morin CM. Is a video-based cognitive behavioral therapy for insomnia as efficacious as a professionally administered treatment in breast cancer? Results of a randomized controlled trial. Sleep. 2014;37(8):1305–14. https://doi.org/10.5665/sleep.3918.

    Article  PubMed  PubMed Central  Google Scholar 

  46. Li JJ, Pang Y, Tang LL. An open controlled study of group psychotherapy on quality of life and mood in patients with lung cancer (in Chinese). Chin Ment Health J. 2014;28(9):657–62. https://doi.org/10.3969/j.issn.1000-6729.2014.09.004.

    Article  Google Scholar 

  47. Yi M, Pang Y, Tang LL. Effects of 10-week group psychotherapy on mood and quality of life in patients with early and mid-term colorectal cancer (in Chinese). Chin Ment Health J. 2015;29(7):491–6. https://doi.org/10.3969/j.issn.1000-6729.2015.07.003.

    Article  Google Scholar 

  48. Zhou ES, Vrooman LM, Manley PE, Crabtree VM, Recklitis CJ. Adapted Delivery of Cognitive-Behavioral Treatment for Insomnia in Adolescent and Young Adult Cancer Survivors: A Pilot Study. Behav Sleep Med. 2017;15(4):288–301. https://doi.org/10.1080/15402002.2015.1126597.

    Article  PubMed  Google Scholar 

  49. Sun ZX, Liu HX, Jiao LY, Zhou T, Yang LN, Fan JY. Reliability and validity of hospital anxiety and depression scale (in Chinese). Chin J Clinicians (Electronic Edition). 2017;11(2):198–201. https://doi.org/10.3877/cma.j.issn.1674-0785.2017.02.005.

    Article  Google Scholar 

  50. Cheng KK, Wong EM, Ling WM, Chan CW, Thompson DR. Measuring the symptom experience of Chinese cancer patients: a validation of the Chinese version of the memorial symptom assessment scale. J Pain Symptom Manage. 2009;37(1):44–57. https://doi.org/10.1016/j.jpainsymman.2007.12.019.

    Article  PubMed  Google Scholar 

  51. Lam WW, Law CC, Fu YT, Wong KH, Chang VT, Fielding R. New insights in symptom assessment: the Chinese Versions of the Memorial Symptom Assessment Scale Short Form (MSAS-SF) and the Condensed MSAS (CMSAS). J Pain Symptom Manage. 2008;36(6):584–95. https://doi.org/10.1016/j.jpainsymman.2007.12.008.

    Article  PubMed  Google Scholar 

  52. Wang CH, Meng Q, Tang XL, Zhang CZ, Lou JH, Zhang XX. Evaluation of FACT- G Chinese version of quality of life scale for cancer patients (in Chinese). J Pract Oncol. 2006;21(1):77–80. https://doi.org/10.3969/j.issn.1001-1692.2006.01.027.

    Article  CAS  Google Scholar 

  53. Watson M, Law M, Dossantos M, Greer S, Baruch J, Bliss J. The Mini-MAC:further development of the mental adjustment to cancer scale. J Psychosoc Oncol. 1994;12:33–46. https://doi.org/10.1300/J077V12N03_03.

    Article  Google Scholar 

  54. Weaver KE, Llabre MM, Lechner SC, Penedo F, Antoni MH. Comparing unidimensional and multidimensional models of benefit finding in breast and prostate cancer. Qual Life Res. 2008;17(5):771–81. https://doi.org/10.1007/s11136-008-9348-z.

    Article  PubMed  Google Scholar 

  55. Gonzalez BD, Manne SL, Stapleton J, Myers-Virtue S, Ozga M, Kissane D, Heckman C, Morgan M. Quality of life trajectories after diagnosis of gynecologic cancer: a theoretically based approach. Support Care Cancer. 2017;25(2):589–98. https://doi.org/10.1007/s00520-016-3443-4.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

We sincerely thank all the participants of the study.

Funding

This study was funded by Shenzhen Natural Science Fund (the Stable Support Plan Program), China. (Grant No: 20200812115712001). Research funder did not participate in research design, data collection, data analysis and publishing writing.

Author information

Authors and Affiliations

  1. Health Science Center, Shenzhen University, A1-403, 1066 Xueyuan Road, Nanshan District, Shenzhen, 518060, China

    Liyuan Sun & Ke Liu

  2. Longgang Central Hospital of Shenzhen, Shenzhen, China

    Yanling Tao

  3. Shenzhen Maternity&Child Healthcare Hospital, Southern Medical University, Shenzhen, China

    Shening Zhu

Authors
  1. Liyuan Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yanling Tao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shening Zhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ke Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

This study is a collaborative work and all authors contributed to the development of this protocol. LYS contributed to grant getting funding for this study and signifcantly contributed to the study protocol writing in consultation with all authors. LYS, YLT and SNZ were responsible for the conception and the design of the study. YLT, SNZ and KL are involved in the project management (e.g. data protection, ethical considerations), data management and data analysis. All authors read and approved the fnal version of the manuscript.

Corresponding author

Correspondence to Liyuan Sun.

Ethics declarations

Ethics approval and consent to participate

The study was conformed to the principles outlined in the Declaration of Helsinki. Research ethical committee approval is obtained by the Research Ethics Committee of Health Science Center in a University of China (approval number: PN-202200015). The registration number with the Chinese Clinical Trial Registry is ChiCTR2100053450. Participants were informed that they could back out of the study at any time, and all collected data were processed anonymously and confidentially. The researchers will ask all patients to sign an informed consent. The methods were performed in accordance with the relevant guidelines and regulations.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sun, L., Tao, Y., Zhu, S. et al. A randomized controlled trial of WeChat-based cognitive behavioral therapy intervention to improve cancer-related symptoms in gynecological cancer survivors: study protocol. BMC Health Serv Res 22, 1052 (2022). https://doi.org/10.1186/s12913-022-08443-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12913-022-08443-y

Keywords

BMC Health Services Research

ISSN: 1472-6963

Contact us